A study found that there is a significant difference in the use and treatment of biomarker testing for non-small cell lung cancer
A biomarker test examines specific disease-related molecules to predict treatment response and disease progression; but its use has made it difficult to detect non-small cell lung cancer (NSCLC). I…
